ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,374,000 | -46.2% | 1,882,768 | -33.7% | 0.03% | -43.5% |
| Q2 2022 | $2,553,000 | -51.0% | 2,837,800 | -18.8% | 0.05% | -45.2% |
| Q1 2022 | $5,206,000 | -31.3% | 3,493,800 | 0.0% | 0.08% | -13.4% |
| Q4 2021 | $7,582,000 | -25.4% | 3,493,800 | +22.3% | 0.10% | -13.4% |
| Q3 2021 | $10,167,000 | -15.7% | 2,856,000 | +36.0% | 0.11% | -8.2% |
| Q2 2021 | $12,054,000 | +10.6% | 2,100,000 | 0.0% | 0.12% | +19.6% |
| Q1 2021 | $10,899,000 | – | 2,100,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |